Clinical Trial

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma

Study acronym: ASTrH
Recruiting
View on ClinicalTrials.gov →
Summary
The study investigates the adjuvant SBRT following TACE in early and intermediate stages HCC not amenable for surgical resection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2021-08-06; most recent amendment 2026-05-05.
Status change: Not Yet Recruiting → Recruiting 2026-05-05
Trial Details
NCT Number NCT04996914
Lead Sponsor RWTH Aachen University
Conditions Hepatocellular Carcinoma Non-resectable
Enrollment 30 participants
Start Date 2026-05-05
Primary Completion 2028-05-05 (estimated)
Study Completion 2029-05-05 (estimated)
Updated on ClinicalTrials.gov 2026-05-11